Skip to main content

Table 1 Characteristics of the study population

From: Implications of the ACC/AHA risk score for prediction of heart failure: the Rotterdam Study

Clinical features

Men (N = 2743)

Women (N = 3646)

P value*

Age, years

68.0 (7.78)

69.2 (8.58)

< 0.001

BMI, kg/m2

26.5 (3.27)

27.3 (4.39)

< 0.001

Systolic blood pressure, mmHg

142 (20.8)

143 (21.5)

0.350

Hear rate, bpm

69.4 (11.9)

71.7 (10.9)

0.032

Total cholesterol, mmol/l

5.54 (0.95)

6.01 (0.95)

< 0.001

HDL, mmol/l

1.24 (0.32)

1.50 (0.40)

< 0.001

Antihypertensive use, N (%)

856 (32.7)

1220 (35.3)

< 0.001

Lipid lowering medication, N (%)

364 (13.8)

420 (12.0)

< 0.001

Creatinine, mmol/l†

89.0 (18.2)

70.8 (13.5)

< 0.001

Glucose, mmol/l

6.09 (1.70)

5.87 (1.47)

< 0.001

LVH, N (%)

176 (7.30)

119 (3.80)

0.034

NT-proBNP, pmol/l†

8.19 (13.4)

10.8 (13.2)

< 0.001

Prevalent CHD, N (%)

370 (13.8)

118 (3.30)

< 0.001

Prevalent diabetes, N (%)

403 (14.7)

423 (11.6)

0.009

Smoking, N (%)

  

< 0.001

 Current

652 (25.3)

614 (17.2)

–

 Past

1604 (62.2)

1315 (36.8)

–

 Never

322 (12.5)

1648 (46.1)

–

  1. Data are mean (standard deviation (SD)) for continuous variables, †median (interquartile range (IQR)) for skewed variables, and number (percentage) for categorical variables from the original data
  2. Proportion of missing: Among men: SBP: 0.18%, heart rate: 0.55%, total cholesterol, BMI and glucose: each 0.9%, HDL: 1.7%, creatinine: 1.6%, NT-proBNP: 1.6%, antihypertensive use: 2%, smoking: 2.7%, LVH: 2.9%
  3. Among women: SBP: 0.86%, heart rate: 1.43%, total cholesterol, glucose: 1.6%, antihypertensive use: 1.8%, smoking: 1.9%, BMI: 2.1%, creatinine: 1.8%, NT-proBNP: 2%, HDL: 2.6%, LVH: 2.6%
  4. BMI body mass index, CHD coronary heart disease, HDL high-density lipoprotein, LVH left ventricular hypertrophy
  5. *P value for differences in characteristics between men and women
Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us